<sup>90</sup>Y-ibritumomab Tiuxetan in B-cell Non-Hodgkin Lymphomas: Real-world Data From the United Arab Emirates.

⁹⁰Y-ibritumomab Tiuxetan in B-cell Non-Hodgkin Lymphomas: Real-world Data From the United Arab Emirates.

Szakács, Zsolt; Lal, Amar; Kristensen, Jorgen; Farkas, Nelli; Ritter, Zsombor; Kiss, Szabolcs; Alizadeh, Hussain; Balikó, Anett.

Afiliação

Szakács Z; Division of Hematology, First Department of Medicine, Medical School, University of Pécs, Pécs, Hungary.
Lal A; Tawam Hospital (in affiliation with Johns Hopkins Medicine), Al Ain, United Arab Emirates.
Kristensen J; Sheikh Khalifa Medical City, Al Tibbiya, Abu Dhabi, United Arab Emirates.
Farkas N; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Ritter Z; Institute of Bioanalysis, Medical School, University of Pécs, Pécs, Hungary.
Kiss S; Division of Nuclear Medicine, Department of Medical Imaging, Medical School, University of Pécs, Pécs, Hungary.
Alizadeh H; Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary.
Balikó A; Doctoral School of Clinical Medicine, University of Szeged, Szeged, Hungary.

Adv Radiat Oncol ; 7(5): 100882, 2022.

Article em En | MEDLINE | ID: mdl-36148378

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article